Previous studies have shown an association of the PPARG Pro12Ala polymorphism with improved insulin sensitivity and reduced risk of type 2 diabetes (26–28), but, in contrast, higher BMI (37,38). Here, PPARG is linked to type 2 diabetes mellitus.